星空体育官方入口网站网址大全-登录入口官网

#Akcea#

4篇内容 | 723人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2035966, encodeId=98882035966ba, content=<a href='/topic/show?id=ad97223210' target=_blank style='color:#2F92EE;'>#Akcea#</a>, objectTitle=研究性反义寡核苷酸疗法AKCEA-ANGPTL3-LRx治疗高甘油三酯血症取得阶段进展, objectType=article, longId=186957, objectId=f46318695ea5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f46318695ea5, replyNumber=0, likeNumber=54, createdTime=2020-03-26, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f46318695ea5, moduleTitle=研究性反义寡核苷酸疗法AKCEA-ANGPTL3-LRx治疗高甘油三酯血症取得阶段进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f46318695ea5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035964, encodeId=f5bb203596484, content=<a href='/topic/show?id=ad97223210' target=_blank style='color:#2F92EE;'>#Akcea#</a>, objectTitle=NEJM：反义寡核苷酸AKCEA-APO(a)-LRx可降低心血管疾病患者脂蛋白A水平, objectType=article, longId=185593, objectId=4513185593bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4513185593bd, replyNumber=0, likeNumber=69, createdTime=2020-10-02, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4513185593bd, moduleTitle=NEJM：反义寡核苷酸AKCEA-APO(a)-LRx可降低心血管疾病患者脂蛋白A水平, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4513185593bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035965, encodeId=738f203596595, content=<a href='/topic/show?id=ad97223210' target=_blank style='color:#2F92EE;'>#Akcea#</a>, objectTitle=因价格问题，英国NICE拒绝Akcea的反义寡链核苷酸药物Waylivra上市, objectType=article, longId=185670, objectId=0d8d1856e076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d8d1856e076, replyNumber=0, likeNumber=118, createdTime=2020-12-04, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d8d1856e076, moduleTitle=因价格问题，英国NICE拒绝Akcea的反义寡链核苷酸药物Waylivra上市, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0d8d1856e076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2035963, encodeId=435a2035963d5, content=<a href='/topic/show?id=ad97223210' target=_blank style='color:#2F92EE;'>#Akcea#</a>, objectTitle=诺华公司获得授权Akcea的新型心血管治疗药物, objectType=article, longId=161113, objectId=0e0d16111313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e0d16111313, replyNumber=0, likeNumber=51, createdTime=2019-10-12, rootId=0, userName=qingrejiedu, userId=2b9b368, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e0d16111313, moduleTitle=诺华公司获得授权Akcea的新型心血管治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0e0d16111313)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Akcea

2020-05-29

qingrejiedu (审核中...)

前往app查看评论内容

#Akcea#

研究性反义寡核苷酸疗法AKCEA-ANGPTL3-LRx治疗高甘油三酯血症取得阶段进展

2020-03-26

qingrejiedu (审核中...)

前往app查看评论内容

#Akcea#

NEJM：反义寡核苷酸AKCEA-APO(a)-LRx可降低心血管疾病患者脂蛋白A水平

2020-10-02

qingrejiedu (审核中...)

前往app查看评论内容

#Akcea#

因价格问题，英国NICE拒绝Akcea的反义寡链核苷酸药物Waylivra上市

2020-12-04

qingrejiedu (审核中...)

前往app查看评论内容

#Akcea#

诺华公司获得授权Akcea的新型心血管治疗药物

2019-10-12

科室
- - 订阅+
  - 更多科室
工具
服务